🇺🇸 FDA
Pipeline program

2wIPV+1sIPV

PRO-sIPV-4005

Approved mab active

Quick answer

2wIPV+1sIPV for Poliomyelitis is a Approved program (mab) at Biotech Pharmaceutical Co., with 1 ClinicalTrials.gov record(s).

Program details

Company
Biotech Pharmaceutical Co.,
Indication
Poliomyelitis
Phase
Approved
Modality
mab
Status
active

Clinical trials